These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3081750

  • 1. 111In-oxine-labelled white blood cells in the diagnosis and follow-up of Crohn's disease.
    Becker W, Fischbach W, Jenett M, Reiners C, Börner W.
    Klin Wochenschr; 1986 Feb 03; 64(3):141-8. PubMed ID: 3081750
    [Abstract] [Full Text] [Related]

  • 2. [111In-oxine marked leukocytes: a method for diagnosing the location and evaluating the activity of Crohn disease and ulcerative colitis].
    Becker W, Fischbach W, Reiners C, Börner W.
    Z Gastroenterol; 1985 Oct 03; 23(10):557-64. PubMed ID: 3936291
    [Abstract] [Full Text] [Related]

  • 3. [Scintigraphic diagnosis of inflammatory small bowel stenoses in Crohn disease using 111In oxine-labeled leukocytes].
    Becker W, Jenett M, Fischbach W, Börner W.
    Rofo; 1986 Jul 03; 145(1):67-74. PubMed ID: 3016823
    [Abstract] [Full Text] [Related]

  • 4. Clinical relevance of activity parameters in Crohn's disease estimated by the faecal excretion of 111In-labeled granulocytes.
    Fischbach W, Becker W.
    Digestion; 1991 Jul 03; 50(3-4):149-52. PubMed ID: 1812041
    [Abstract] [Full Text] [Related]

  • 5. [111In-oxine-labeled granulocytes in Crohn disease and ulcerative colitis. Labeling and study technics].
    Becker W, Fischbach W, Reiners C, Börner W.
    Rofo; 1985 Mar 03; 142(3):320-5. PubMed ID: 2984737
    [Abstract] [Full Text] [Related]

  • 6. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label.
    Schölmerich J, Schmidt E, Schümichen C, Billmann P, Schmidt H, Gerok W.
    Gastroenterology; 1988 Nov 03; 95(5):1287-93. PubMed ID: 3169496
    [Abstract] [Full Text] [Related]

  • 7. Radiolabelled granulocytes in inflammatory bowel disease: diagnostic possibilities and clinical indications.
    Becker W, Fischbach W, Weppler M, Mosl B, Jacoby G, Börner W.
    Nucl Med Commun; 1988 Oct 03; 9(10):693-701. PubMed ID: 3062507
    [Abstract] [Full Text] [Related]

  • 8. Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease.
    Saverymuttu SH, Peters AM, Lavender JP, Pepys MB, Hodgson HJ, Chadwick VS.
    Gastroenterology; 1983 Dec 03; 85(6):1333-9. PubMed ID: 6628930
    [Abstract] [Full Text] [Related]

  • 9. In vivo assessment of granulocyte migration to diseased bowel in Crohn's disease.
    Saverymuttu SH, Peters AM, Lavender JP, Chadwick VS, Hodgson HJ.
    Gut; 1985 Apr 03; 26(4):378-83. PubMed ID: 3979910
    [Abstract] [Full Text] [Related]

  • 10. Three-phase white blood cell scan: diagnostic validity in abdominal inflammatory diseases.
    Becker W, Fischbach W, Reiners C, Börner W.
    J Nucl Med; 1986 Jul 03; 27(7):1109-15. PubMed ID: 3088223
    [Abstract] [Full Text] [Related]

  • 11. 111In-oxine-labelled autologous leucocytes in inflammatory bowel disease: new scintigraphic activity index.
    Ybern A, Martin-Comin J, Giné JJ, Casanovas T, Villa R, Gassull MA.
    Eur J Nucl Med; 1986 Jul 03; 11(9):341-4. PubMed ID: 3082637
    [Abstract] [Full Text] [Related]

  • 12. Localization and activity of inflammatory bowel disease using 111In leukocyte imaging.
    Hotze A, Briele B, Wolf F, Biersack HJ, Knapp FF.
    Nuklearmedizin; 1988 Jun 03; 27(3):83-6. PubMed ID: 3136443
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of indium scintigraphy in patients with active inflammatory bowel disease.
    Buxton-Thomas MS, Dickinson RJ, Maltby P, Hunter JO, Wraight EP.
    Gut; 1984 Dec 03; 25(12):1372-5. PubMed ID: 6439610
    [Abstract] [Full Text] [Related]

  • 14. Autologous 111In-oxine-labeled granulocytes in Yersinia infections.
    Becker W, Fischbach W, Börner W.
    Eur J Nucl Med; 1985 Dec 03; 10(7-8):377-8. PubMed ID: 3924620
    [Abstract] [Full Text] [Related]

  • 15. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion.
    Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJ, Chadwick VS.
    Gastroenterology; 1986 May 03; 90(5 Pt 1):1121-8. PubMed ID: 3956932
    [Abstract] [Full Text] [Related]

  • 16. Indium-111-labeled autologous leukocyte imaging and fecal excretion. Comparison with conventional methods of assessment of inflammatory bowel disease.
    Leddin DJ, Paterson WG, DaCosta LR, Dinda PK, Depew WT, Markotich J, McKaigney JP, Groll A, Beck IT.
    Dig Dis Sci; 1987 Apr 03; 32(4):377-87. PubMed ID: 3829880
    [Abstract] [Full Text] [Related]

  • 17. Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: diagnostic and clinical relevance.
    Sciarretta G, Furno A, Mazzoni M, Basile C, Malaguti P.
    Gut; 1993 Oct 03; 34(10):1364-9. PubMed ID: 8244102
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM, Liu T, Gao S, Tong XD, Deng FH, Nie B.
    World J Gastroenterol; 2017 Dec 14; 23(46):8235-8247. PubMed ID: 29290660
    [Abstract] [Full Text] [Related]

  • 19. [Gammagraphy using indium 111-labeled leukocytes in inflammatory intestinal disease].
    Casellas F, Aguadé S, Soriano B, Accarino A, Vargas V, Guarner L.
    Med Clin (Barc); 1985 Jun 22; 85(4):129-32. PubMed ID: 3928992
    [No Abstract] [Full Text] [Related]

  • 20. 111Indium autologous leucocytes in inflammatory bowel disease.
    Saverymuttu SH, Peters AM, Lavender JP, Hodgson HJ, Chadwick VS.
    Gut; 1983 Apr 22; 24(4):293-9. PubMed ID: 6832626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.